Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool

Mark D. Huffman; Laine E. Thomas

doi:10.1001/jamacardio.2018.2270

Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	907
Number of pages	1
Journal	JAMA Cardiology
Volume	3
Issue number	10
DOIs	https://doi.org/10.1001/jamacardio.2018.2270
State	Published - Oct 2018

Access to Document

10.1001/jamacardio.2018.2270

Cite this

@article{d90aacbd93634f218c20be552eea70db,

title = "Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool",

author = "Huffman, {Mark D.} and Thomas, {Laine E.}",

note = "Funding Information: Disclosure of Potential Conflicts of Interest. Dr Huffman receives funding from the World Heart Federation to serve as its senior program advisor for the Emerging Leaders program, which is sponsored by Boehringer Ingelheim and Novartis. Dr Huffman also receives support from the American Heart Association, Verily, and AstraZeneca for work to develop a surveillance system of the US food supply in collaboration with The George Institute for Global Health. Dr Thomas receive research funding from Novartis.",

year = "2018",

month = oct,

doi = "10.1001/jamacardio.2018.2270",

language = "English",

volume = "3",

pages = "907",

journal = "JAMA Cardiology",

issn = "2380-6583",

number = "10",

}

TY - JOUR

T1 - Tools for Evaluating and Improving Causal Inference

T2 - Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool

AU - Huffman, Mark D.

AU - Thomas, Laine E.

N1 - Funding Information: Disclosure of Potential Conflicts of Interest. Dr Huffman receives funding from the World Heart Federation to serve as its senior program advisor for the Emerging Leaders program, which is sponsored by Boehringer Ingelheim and Novartis. Dr Huffman also receives support from the American Heart Association, Verily, and AstraZeneca for work to develop a surveillance system of the US food supply in collaboration with The George Institute for Global Health. Dr Thomas receive research funding from Novartis.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85052744349&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2018.2270

DO - 10.1001/jamacardio.2018.2270

M3 - Editorial

C2 - 30073323

AN - SCOPUS:85052744349

SN - 2380-6583

VL - 3

SP - 907

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 10

ER -

Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool

Access to Document

Other files and links

Cite this